Over its long corporate history across various independent regional entities, the Blue Cross Blue Shield association has faced several high-profile legal and regulatory controversies. These typically involved antitrust lawsuits regarding market allocation agreements among regional licensees, disputes over executive compensation packages, and regulatory scrutiny regarding reserve fund accumulations, claim denial practices, and transparency in healthcare billing networks.